BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17558835)

  • 1. Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy.
    Konuk O; Hondur A; Akyurek N; Unal M
    Ocul Immunol Inflamm; 2007; 15(2):105-11. PubMed ID: 17558835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and antioxidant activity in orbital fibroadipose tissue in Graves' ophthalmopathy.
    Hondur A; Konuk O; Dincel AS; Bilgihan A; Unal M; Hasanreisoglu B
    Curr Eye Res; 2008 May; 33(5):421-7. PubMed ID: 18568878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclooxygenase-2 in orbital fibroadipose connective tissues of Graves' ophthalmopathy patients.
    Konuk EB; Konuk O; Misirlioglu M; Menevse A; Unal M
    Eur J Endocrinol; 2006 Nov; 155(5):681-5. PubMed ID: 17062883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of macrophage infiltration in the orbital fat of patients with Graves' ophthalmopathy.
    Chen MH; Chen MH; Liao SL; Chang TC; Chuang LM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):332-7. PubMed ID: 18284633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Somatostatin receptor genes expression and effects of octreotide on orbital fibroblasts from Graves' ophthalmopathy].
    Pasquali D; Notaro A; Esposito D; Vassallo P; Bonavolontà G; Bellastella A; Sinisi AA
    Minerva Endocrinol; 2001 Sep; 26(3):175-9. PubMed ID: 11753241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy.
    Feldon SE; Park DJ; O'Loughlin CW; Nguyen VT; Landskroner-Eiger S; Chang D; Thatcher TH; Phipps RP
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3913-21. PubMed ID: 16249464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
    Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
    Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease.
    Bufalo NE; Santos RB; Cury AN; Andrade RA; Morari J; Morari EC; Leite JL; Monte O; Romaldini JH; Ward LS
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):982-7. PubMed ID: 17980001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Floretlike cells in in situ and prolapsed orbital fat.
    Ebrahimi KB; Ren S; Green WR
    Ophthalmology; 2007 Dec; 114(12):2345-9. PubMed ID: 17822769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysosome-related genes are regulated in the orbital fat of patients with graves' ophthalmopathy.
    Chen MH; Liao SL; Chen MH; Tsou PL; Shih MJ; Chang TC; Chuang LM
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4760-4. PubMed ID: 18552385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Graves' ophthalmopathy may be a risk factor for the development of postthyroidectomy hypocalcaemia.
    Hassan I; Danila R; Maurer E; Osei-Agymang T; Zielke A
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):614-8. PubMed ID: 18523918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct orbital manometry in patients with thyroid-associated orbitopathy.
    Riemann CD; Foster JA; Kosmorsky GS
    Ophthalmology; 1999 Jul; 106(7):1296-302. PubMed ID: 10406609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Graves' ophthalmopathy].
    Badelon I; Morax S
    Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin in orbital tissues from patients with thyroid-associated ophthalmopathy: predominant localization in fibroadipose tissue.
    Lisi S; Marinò M; Pinchera A; Mazzi B; Di Cosmo C; Sellari-Franceschini S; Chiovato L
    Thyroid; 2002 May; 12(5):351-60. PubMed ID: 12097194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on pathology and immunoglobulin of orbital tissues from cases with Grave's ophthalmopathy].
    Zhou X; Luo Q; Xia R
    Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):271-3, 18. PubMed ID: 11835820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs.
    Cozma I; Zhang L; Uddin J; Lane C; Rees A; Ludgate M
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1630-5. PubMed ID: 17848636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease.
    Sato H; Shiraishi I; Takamatsu T; Hamaoka K
    J Mol Cell Cardiol; 2007 Sep; 43(3):254-61. PubMed ID: 17631310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Graves' orbitopathy in Latin America: an international questionnaire study compared with Europe.
    Ramos HE; Diehl LA; Camacho CP; Perros P; Graf H;
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):951-6. PubMed ID: 18462263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.